Moreover, treatment of shikonin (a specific inhibitor of PKM) markedly suppressed TET2 knockout-induced productions of Lactate and PEP (Fig. 5e), suggesting that TET2 inhibiting glycolysis in NPC cells depends on PKM. The gene discussed is PKM; the disease is nasopharyngeal carcinoma.